The Impact of Training on Sitting Time and Brain Volumes in Multiple Sclerosis. (EXIMS)

August 30, 2021 updated by: Bert Op't Eijnde, Hasselt University

The Impact of Structured Exercise on Physical Fitness, Sedentary Time, Brain Volume, Cognitive, Health-related and Immunological Parameters in Multiple Sclerosis.

The current study aims to investigate whether persons with Multiple Sclerosis (PwMS) compensate training time with more sedentary time and consequently blunt training effects. The second aim will be to investigate the effect of a structured training program on specific brain volumes and cognitive variables.

Study Overview

Status

Completed

Conditions

Detailed Description

Multiple Sclerosis is a progressive, autoimmune, neurodegenerative disorder of the central nervous system (CNS) that predominantly affects young to middle-aged adults. It is characterized by a chronic inflammatory process that causes demyelination, axonal damage and white matter lesions across the CNS. Furthermore, evidence also indicates grey matter (GM) atrophy which has been reported to be significantly correlated with both clinical and cognitive deterioration. Clinical manifestations include spasticity, tremor, paralysis, walking difficulties and cognitive abnormalities. Due to these primary disease symptoms, persons with MS (PwMS) appear to be susceptible to a sedentary lifestyle and inactivity, which consequently increases the risk of other important, health-related secondary deficits including respiratory, metabolic and cardiac dysfunction. These deficits further contribute to a decrease in cardiorespiratory fitness and quality of life (QoL), thereby causing a vicious circle of decreased exercise tolerance, greater disability and increased inactivity. Since pharmacological treatment has little impact on these secondary deficits, exercise therapy has become an important aspect of the treatment of MS.

Hence, exercise therapy interventions in MS have been studied extensively and have already been proven to significantly improve cardiorespiratory fitness, muscle strength, balance, fatigue, cognition, quality of life, respiratory function and brain volumes. Moreover, a dose-response relationship has been reported for functional variables such as strength and endurance capacity. As such, high intensity interval training (HIIT) probably is exerts superior effects compared to traditional low/moderate intensity continuous training (MICT). However and in contrast with other populations, effects of HIIT on important health-related variables such as body composition, blood pressure and blood lipid profiles are less evident. Possibly, PwMS do not reach the exercise intensities required to improve such factors due to cardiovascular autonomic dysfunction, leading to impaired carotid baroreflex control, attenuated elevations in blood pressure and disturbed increases in heart rate, and abnormal muscle energy metabolism. Moreover, higher intensities might hamper longer-term implementation in real life, as an inverse relation between exercise intensity and training adherence has already been reported.

Training periodization (alternating HIIT and MICT) offers a solution to overcome the barrier of adherence and concurrently augmenting training effects, but in contrast to other populations, the addition of a lower intensity training component does still not improve health-related variables. Therefore, other approaches are warranted. Recently, evidence is growing that sedentary time is an important health risk factor, independent of the (dis)practice of structured exercise. Hence, PwMS possibly compensate training effects with even more sedentary time, in addition to an already sedentary lifestyle as mentioned previously. As such, addressing sedentary time might be an interesting new approach to counteract the health-related deficits in PwMS. Therefore, the present study explores the impact of a structured exercise program on sedentary time and health-related variables.

Furthermore, a secondary aim of the current project is to investigate the effect of a periodized training program on brain volumes and cognitive function. Recent evidence of physical training effects on cognitive variables is contradictory. So for exercise intervention studies that studied the latter only used short-term and laboratory-based training programs and included exercise modalities (type, intensity, duration) that are difficult to compare. Interestingly, a recent short-term randomized controlled trial reported superior effects of HIIT on cognitive functions compared to MICT. Hence, the current study aims to investigate the impact of a long-term, home-based training program with HIIT-components on cognitive variables.

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Diepenbeek, Limburg, Belgium, 3590
        • Hasselt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Multiple Sclerosis according to the McDonald criteria (Relaps remitting)
  • Written informed consent
  • Medical safety screening

Exclusion Criteria:

  • Contra-indications to participate in moderate to high intensity exercise
  • Contra-indications to undergo magnetic resonance imaging (pacemaker/defibrillator or wires other than sternal wires, insulin pumps, metal foreign bodies, deep brain stimulator, cerebral aneurysm clips, cochlear implant, magnetic dental implant, drug infusion device)
  • Medication changes in the last month before the start of the intervention
  • Following or plan to follow a weight reduction program
  • Pregnancy
  • Participation in another study
  • Acute MS exacerbation < 3 months prior to the start of the study
  • EDSS score > 4
  • Consumption of more than 20 alcohol units/week
  • No daily internet access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: MS - training goal 1
Persons with Multiple Sclerosis (PwMS) with a 'poor VO2max', a 'fair VO2max' with no running experience and a 'good VO2max' with no running experience (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the first training group will be trained to run continuously for 45 minutes.
All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.
EXPERIMENTAL: HC - training goal 1
Healthy control (HC) persons with a 'poor VO2max', a 'fair VO2max' with no running experience and a 'good VO2max' with no running experience (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the first training group will be trained to run continuously for 45 minutes.
All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.
EXPERIMENTAL: MS - training goal 2
PwMS with a 'fair VO2max' and running experience, a 'good VO2max and running experience', an 'excellent VO2max' and a 'superior VO2max' (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the second training group will be trained to run continuously for 75 minutes.
All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.
EXPERIMENTAL: HC - training goal 2
HC with a 'fair VO2max' and running experience, a 'good VO2max and running experience', an 'excellent VO2max' and a 'superior VO2max' (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the second training group will be trained to run continuously for 75 minutes.
All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.
NO_INTERVENTION: MS - sedentary control group
Twenty PwMS will receive no intervention, only usual care.
NO_INTERVENTION: HC - sedentary control group
Twenty HC will receive no intervention, only usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of steps per day
Time Frame: Before start of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Before start of the training program
Number of steps per day
Time Frame: Week 1 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 1 of the training program
Number of steps per day
Time Frame: Week 24 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 24 of the training program
Number of steps per day
Time Frame: Week 48 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 48 of the training program
Number of steps per day
Time Frame: 3 months after the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
3 months after the training program
Sitting time
Time Frame: Before start of the training program
Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Before start of the training program
Sitting time
Time Frame: Week 1 of the training program
Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 1 of the training program
Sitting time
Time Frame: Week 24 of the training program
Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 24 of the training program
Sitting time
Time Frame: Week 48 of the training program
Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 48 of the training program
Sitting time
Time Frame: 3 months after the training program
Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
3 months after the training program
Standing time
Time Frame: Before start of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Before start of the training program
Standing time
Time Frame: Week 1 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 1 of the training program
Standing time
Time Frame: Week 24 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 24 of the training program
Standing time
Time Frame: Week 48 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 48 of the training program
Standing time
Time Frame: 3 months after the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
3 months after the training program
Stepping time
Time Frame: Before start of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Before start of the training program
Stepping time
Time Frame: Week 1 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 1 of the training program
Stepping time
Time Frame: Week 24 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 24 of the training program
Stepping time
Time Frame: Week 48 of the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
Week 48 of the training program
Stepping time
Time Frame: 3 months after the training program
Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).
3 months after the training program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: Baseline
Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.
Baseline
Blood pressure
Time Frame: Week 48 of the training program
Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.
Week 48 of the training program
Resting heart rate
Time Frame: Baseline
Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.
Baseline
Resting heart rate
Time Frame: Week 48 of the training program
Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.
Week 48 of the training program
Total calorie intake
Time Frame: Baseline
Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.
Baseline
Total calorie intake
Time Frame: Week 12 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.
Week 12 of the training program
Total calorie intake
Time Frame: Week 24 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.
Week 24 of the training program
Total calorie intake
Time Frame: Week 48 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.
Week 48 of the training program
Total calorie intake
Time Frame: 3 months after the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.
3 months after the training program
Macronutrient content
Time Frame: Baseline
Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.
Baseline
Macronutrient content
Time Frame: Week 12 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.
Week 12 of the training program
Macronutrient content
Time Frame: Week 24 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.
Week 24 of the training program
Macronutrient content
Time Frame: Week 48 of the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.
Week 48 of the training program
Macronutrient content
Time Frame: 3 months after the training program
Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.
3 months after the training program
Participation - Ghent Participation Scale (GPS)
Time Frame: Baseline
The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS.
Baseline
Participation - Ghent Participation Scale (GPS)
Time Frame: Week 48 of the training program
The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS.
Week 48 of the training program
Mobility - MS walking scale (MSWS-12)
Time Frame: Baseline
The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group
Baseline
Mobility - MS walking scale (MSWS-12)
Time Frame: Week 48 of the training program
The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group
Week 48 of the training program
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: Before start of the intervention
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
Before start of the intervention
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: Week 1 of the intervention
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
Week 1 of the intervention
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: Week 12 of the training program
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
Week 12 of the training program
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: Week 24 of the training program
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
Week 24 of the training program
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: Week 48 of the training program
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
Week 48 of the training program
Fatigue - Modified Fatigue Impact scale (MFIS)
Time Frame: 3 months after the training program
To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.
3 months after the training program
Cognition - Spatial Recall test (SPART)
Time Frame: Baseline
The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group
Baseline
Cognition - Spatial Recall test (SPART)
Time Frame: Week 48 of the training program
The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group
Week 48 of the training program
Cognition - Symbol Digit Modalities Test (SDMT)
Time Frame: Baseline
The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended.
Baseline
Cognition - Symbol Digit Modalities Test (SDMT)
Time Frame: Week 48 of the training program
The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended.
Week 48 of the training program
Body weight
Time Frame: Baseline
Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg
Baseline
Body weight
Time Frame: Week 48 of the training program
Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg
Week 48 of the training program
Height
Time Frame: Baseline
Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot
Baseline
Height
Time Frame: Week 48 of the training program
Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot
Week 48 of the training program
DEXA (Dual Energy X-Ray)
Time Frame: Baseline
body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry
Baseline
DEXA (Dual Energy X-Ray)
Time Frame: Week 48 of the training program
body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry
Week 48 of the training program
Coordination - timed tandem walk (TTW)
Time Frame: Baseline
Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored.
Baseline
Coordination - timed tandem walk (TTW)
Time Frame: Week 48 of the training program
Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored.
Week 48 of the training program
Oxygen uptake (VO2)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds.
Baseline
Oxygen uptake (VO2)
Time Frame: Week 48 of the training program
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training program
Carbon dioxide output (VCO2)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds.
Baseline
Carbon dioxide output (VCO2)
Time Frame: Week 48 of the training protocol
Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training protocol
Minute ventilation (VE)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds.
Baseline
Minute ventilation (VE)
Time Frame: Week 48 of the training protocol
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training protocol
Equivalents for oxygen uptake (VE/VO2)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds.
Baseline
Equivalents for oxygen uptake (VE/VO2)
Time Frame: Week 48 of the training protocol
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training protocol
Equivalents for carbon dioxide production (VE/VCO2)
Time Frame: Baseline
Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds.
Baseline
Equivalents for carbon dioxide production (VE/VCO2)
Time Frame: Week 48 of the training program
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training program
Tidal volume (Vt)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds.
Baseline
Tidal volume (Vt)
Time Frame: Week 48 of the training program
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training program
Breathing frequency (BF)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds.
Baseline
Breathing frequency (BF)
Time Frame: Week 48 of the training protocol
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training protocol
Respiratory gas exchange ratio (RER)
Time Frame: Baseline
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds.
Baseline
Respiratory gas exchange ratio (RER)
Time Frame: Week 48 of the training program
Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds.
Week 48 of the training program
Cardiorespiratory fitness (CRF)
Time Frame: Baseline
CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer.
Baseline
Cardiorespiratory fitness (CRF)
Time Frame: Week 48 of the training program
CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer.
Week 48 of the training program
Lipidomic profile
Time Frame: Baseline
Blood analysis
Baseline
Lipidomic profile
Time Frame: Week 48 of the training program
Blood analysis
Week 48 of the training program
Brain volumes
Time Frame: Baseline
MRI scan
Baseline
Brain volumes
Time Frame: Week 48 of the training program
MRI scan
Week 48 of the training program
PBMC subset parameters
Time Frame: Baseline
flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs)
Baseline
PBMC subset parameters
Time Frame: Week 48 of the training program
flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs)
Week 48 of the training program
serum cytokines
Time Frame: Baseline
cytokine levels are measured by ELISA on serum derived from peripheral blood samples
Baseline
serum cytokines
Time Frame: Week 48 of the training program
cytokine levels are measured by ELISA on serum derived from peripheral blood samples
Week 48 of the training program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 15, 2020

Primary Completion (ACTUAL)

June 30, 2021

Study Completion (ACTUAL)

June 30, 2021

Study Registration Dates

First Submitted

December 5, 2019

First Submitted That Met QC Criteria

December 5, 2019

First Posted (ACTUAL)

December 10, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 31, 2021

Last Update Submitted That Met QC Criteria

August 30, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Periodized, home-based running program

3
Subscribe